mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
4e-11 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-10 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-10 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-10 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-10 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-10 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
4e-10 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-10 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
2e-09 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-09 |